BioCentury
ARTICLE | Clinical News

BioChaperone PDGF-BB: Phase III started

September 1, 2014 7:00 AM UTC

Adocia began a double-blind, placebo-controlled, Indian Phase III trial to evaluate BioChaperone PDGF-BB spray in 252 Type I and II diabetics with a chronic foot ulcer. In 4Q15, the company also plans...